The Animas corporation announced that Animas Vibe, the first and only continuous glucose monitoring (CGM)-enabled insulin pump system with Dexcom G4™ CGM technology, received the CE Mark of approval. The Animas® Vibe combines the features of an Animas insulin pump with the convenience of Dexcom CGM, which is the only sensor approved for up to seven days of wear.
As a CGM-enabled system, the Animas Vibe insulin pump functions as a receiver for the Dexcom G4 Sensor. The system delivers real-time glucose information, alerts for high and low readings, and glucose trend information, enabling patients to make more informed decisions to help control their disease. The new system offers a color display and is waterproof.
Now approved in Europe, the Animas Vibe will initially be available to people living with diabetes in the United Kingdom, Germany, France, Italy and Sweden.
The FDA in the states should be ashamed of themselves for not getting this approved in the US…
Congrats to diabetics in Europe. You have the best pump on the market now.